Candriam
Overview
Candriam is a global multi-specialist asset manager and a recognized pioneer in sustainable and responsible investing, offering solutions across fixed income, equities, absolute return, multi-asset, and private markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| IZNES | May 2021 | VC Round | Co-investor |
| Ganymed Robotics | Jul 2022 | Series B | Co-investor |
| Egle Therapeutics | Oct 2021 | Series A | Co-investor |
Key People
Anaëlle Stamatiou
Portfolio Manager
filip corten
Senior Portfolio Manager
Gilles Fabri
Senior Portfolio Manager - Fixed Income
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Candriam based?
Candriam is headquartered in Strassen, Luxembourg.
When was Candriam founded?
Candriam was founded in 1996.
How many portfolio companies does Candriam have?
Candriam has 3 portfolio companies in Caplight's dataset.
What are some companies in Candriam's portfolio?
Portfolio companies visible on Caplight include IZNES, Ganymed Robotics, Egle Therapeutics.
What was Candriam's most recent investment shown here?
Candriam's most recent investment in this portfolio sample was in Ganymed Robotics in 2022.
What sectors does Candriam focus on?
Candriam focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Crypto & Web3, Frontier & Industrial Tech.
What company stages does Candriam focus on?
Stage focus information for Candriam is not publicly available.
What is Candriam's AUM?
Candriam's assets under management are estimated between $183.0B and $183.0B.